Loading
A gut potassium binder (Veltassa) used to manage chronic hyperkalemia and enable RAAS inhibitor therapy.
Patiromer exchanges calcium for potassium in the colon, lowering serum potassium over hours to days. It supports continued use of ACE inhibitors/ARBs and mineralocorticoid antagonists in heart/kidney disease. Side effects include hypomagnesemia, constipation, and hypokalemia. Separate dosing from other oral medications by several hours.
High potassium in the blood — a common and potentially dangerous complication of CKD, especially with ACEi/ARB therapy — causing heart rhythm disturbances at severe levels.
A medication that binds potassium in the gut to lower blood potassium — allowing patients with CKD to stay on protective ACEi/ARB therapy.
A newer potassium binder (Lokelma) that removes potassium through the gut in chronic hyperkalemia.
A blood-pressure drug (e.g., ramipril, lisinopril, enalapril) that also protects the kidneys by reducing protein leakage.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.